Abi Pesun, director at Almac ONE explains how a shift towards unified supply chain management can accelerate timelines and help mitigate risk for clinical trials during Covid-19.
EPM speaks to Alex Guite, vice president of Services and Alliances at World Courier about the impact Covid-19 has had on the clinical trials sector and how a direct-to-patient approach can help trials continue.
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the issue of diversity in clinical trials and how medicines aren't developed with every patient in mind.
Dr Peter Jackson, executive director of the AMR Centre explains why a new clinical trial taking place in the UK could represent a major step forward in the fight against antimicrobial resistance (AMR).
Leah Shifra Price, freelance biostatistician at freelance platform for scientists Kolabtree, discusses how a flexible workforce can speed up trials and remove delays in clinical trials.
Sanjay Vyas, corporate vice president & Global SBU head of Clinical Trial Supplies & Logistics, PAREXEL International discusses the challenges in transporting certain medicines and how advancements in technology are making things easier.
Torkel Gren, Recipharm and Anders Millerhovf, CTC Clinical Trial Consultants discuss the steps needed for drug formulation during first-in-human (FIH) trials, if regulatory approval is to be achieved.
